Purpose of the study : To evaluate the antitumoral effect of two therapeutic procedures and to evaluate their respective toxicity on the CNS.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
140
40 Gy
intensive chemotherapy and hematopoietic stem cell rescue
R-MBVP 2 cycles day1 and day28 followed by R-Aracytine 2 cycles days58\&59 and days79\&80
Cancérologie Hôpital Sud
Amiens, France
Chu D'Angers
Angers, France
2-years progression-free survival in each arm
Time frame: 2 years after inclusion
Overall response rate at the end of the procedure
Time frame: at the end of procedure at 1 and 2 years
Overall survival
Time frame: 2 years after inclusion
Event-free survival
Time frame: 2 years after inclusion
Neurotoxicity
Time frame: each years during ten years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHR Argenteuil
Argenteuil, France
CHU de Besancon
Besançon, France
Institut Bergonié
Bordeaux, France
CHU Hôtel Dieu
Clermont-Ferrand, France
CHU Michalon
Grenoble, France
Centre Hospitalier Lens
Lens, France
CHU de Limoges
Limoges, France
CHU de la Timone
Marseille, France
...and 13 more locations